These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 25874901)
1. Smart nanoparticles as targeting platforms for HIV infections. Adhikary RR; More P; Banerjee R Nanoscale; 2015 May; 7(17):7520-34. PubMed ID: 25874901 [TBL] [Abstract][Full Text] [Related]
2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
3. Progress in antiretroviral drug delivery using nanotechnology. Mallipeddi R; Rohan LC Int J Nanomedicine; 2010 Aug; 5():533-47. PubMed ID: 20957115 [TBL] [Abstract][Full Text] [Related]
4. Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting. Gupta U; Jain NK Adv Drug Deliv Rev; 2010 Mar; 62(4-5):478-90. PubMed ID: 19913579 [TBL] [Abstract][Full Text] [Related]
5. Role of integrated cancer nanomedicine in overcoming drug resistance. Iyer AK; Singh A; Ganta S; Amiji MM Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506 [TBL] [Abstract][Full Text] [Related]
6. Programmable nanomedicine: synergistic and sequential drug delivery systems. Pacardo DB; Ligler FS; Gu Z Nanoscale; 2015 Feb; 7(8):3381-91. PubMed ID: 25631684 [TBL] [Abstract][Full Text] [Related]
7. Recent advances in "smart" delivery systems for extended drug release in cancer therapy. Kalaydina RV; Bajwa K; Qorri B; Decarlo A; Szewczuk MR Int J Nanomedicine; 2018; 13():4727-4745. PubMed ID: 30154657 [TBL] [Abstract][Full Text] [Related]
8. Trigger responsive polymeric nanocarriers for cancer therapy. Kaur S; Prasad C; Balakrishnan B; Banerjee R Biomater Sci; 2015 Jul; 3(7):955-87. PubMed ID: 26221933 [TBL] [Abstract][Full Text] [Related]
9. Advancements in nano-enabled therapeutics for neuroHIV management. Kaushik A; Jayant RD; Nair M Int J Nanomedicine; 2016; 11():4317-25. PubMed ID: 27621624 [TBL] [Abstract][Full Text] [Related]
10. Stimulus-responsive targeted nanomicelles for effective cancer therapy. Muthu MS; Rajesh CV; Mishra A; Singh S Nanomedicine (Lond); 2009 Aug; 4(6):657-67. PubMed ID: 19663594 [TBL] [Abstract][Full Text] [Related]
11. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy. Pérez-Herrero E; Fernández-Medarde A Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885 [TBL] [Abstract][Full Text] [Related]
12. Drug delivery systems in HIV pharmacotherapy: what has been done and the challenges standing ahead. Sosnik A; Chiappetta DA; Carcaboso AM J Control Release; 2009 Aug; 138(1):2-15. PubMed ID: 19445981 [TBL] [Abstract][Full Text] [Related]
13. Biodegradable Smart Nanogels: A New Platform for Targeting Drug Delivery and Biomedical Diagnostics. Wu HQ; Wang CC Langmuir; 2016 Jun; 32(25):6211-25. PubMed ID: 27255455 [TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. Zhang H; Dornadula G; Beumont M; Livornese L; Van Uitert B; Henning K; Pomerantz RJ N Engl J Med; 1998 Dec; 339(25):1803-9. PubMed ID: 9854115 [TBL] [Abstract][Full Text] [Related]
15. Nanomicrobicides for HIV vaginal transmission prevention: where do we stand? Agrahari V Ther Deliv; 2017 Jul; 8(8):601-606. PubMed ID: 28730940 [No Abstract] [Full Text] [Related]
16. The prevalence of antiretroviral multidrug resistance in highly active antiretroviral therapy-treated patients with HIV/AIDS between 2004 and 2009 in South Korea. Choi JY; Kwon OK; Choi BS; Kee MK; Park M; Kim SS J Clin Virol; 2014 Jun; 60(2):154-60. PubMed ID: 24680255 [TBL] [Abstract][Full Text] [Related]
17. Human Vault Nanoparticle Targeted Delivery of Antiretroviral Drugs to Inhibit Human Immunodeficiency Virus Type 1 Infection. Fulcher JA; Tamshen K; Wollenberg AL; Kickhoefer VA; Mrazek J; Elliott J; Ibarrondo FJ; Anton PA; Rome LH; Maynard HD; Deming T; Yang OO Bioconjug Chem; 2019 Aug; 30(8):2216-2227. PubMed ID: 31265254 [TBL] [Abstract][Full Text] [Related]
18. Nanoparticles for cancer therapy using magnetic forces. Tietze R; Lyer S; Dürr S; Alexiou C Nanomedicine (Lond); 2012 Mar; 7(3):447-57. PubMed ID: 22385201 [TBL] [Abstract][Full Text] [Related]
19. Stimuli-sensitive nanopreparations for combination cancer therapy. Jhaveri A; Deshpande P; Torchilin V J Control Release; 2014 Sep; 190():352-70. PubMed ID: 24818767 [TBL] [Abstract][Full Text] [Related]